Get the full picture
Sign in to uncover key details.
Show More
Structure
Manufacturing · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
601 Gateway Blvd Ste 900, South San Fran...Phone Number
(650) 457-1978Website
www.structuretx.comRevenue
-Stock Symbol
GPCRIndustry
About Structure
Structure Therapeutics is a science-driven, clinicalstage biopharmaceutical company committed to discovering and developing innovative oral smallmolecule therapies for chronic metabolic and cardiopulmonary diseases that currently lack effective treatments. Leveraging a nextgeneration structure-based drug discovery platform, the company focuses on targeting Gproteincoupled receptors (GPCRs) to build a robust pipeline of proprietary smallmolecule compounds. By prioritizing oral therapies over traditional biologic or peptide approaches, Structure Therapeutics aims to deliver scalable, accessible treatments that can reach more patients worldwide and address significant unmet medical needs.Explore more
Structure Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Structure
Compare insights from companies similar to Structure, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Structure Tech Stack
A closer look at the technologies used by Structure
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Structure
Sign Up For FreeTo access detailed company insights
Structure Therapeutics is a science-driven, clinicalstage biopharmaceutical company committed to discovering and developing innovative oral smallmolecule therapies for chronic metabolic and cardiopulmonary diseases that currently lack effective treatments. Leveraging a nextgeneration structure-based drug discovery platform, the company focuses on t... Read More
